Our Mission
Alzheimer's disease and dementia devastate lives. Join us in the fight against these debilitating illnesses.
Welcome
The Think Clinic is a physician-led telehealth platform dedicated to the emerging field of ocular nootropics—medical science connecting the eyes, brain, and metabolic health.
We are exclusively authorized to prescribe Claridrops™, a patent-pending proprietary insulin-based ophthalmic formulation designed to penetrate into the Central Nervous System (CNS). In the CNS, insulin has been studied to enhance neuronal glucose signaling, metabolism and synaptic plasticity.
We connect patients with licensed physicians who provide personalized teleconsultations to ensure that Claridrops™ are precisely prescribed and ethically delivered.
Claridrops™ are compounded exclusively at our partner pharmacy.
Clarity in a Drop
A revolutionary ophthalmic insulin formulation designed to penetrate into the Central Nervous System (CNS) to enhance neuronal glucose metabolism, signaling and synaptic plasticity.*
A novel route to the brain—through the eye. Insulin targets cognitive metabolism and neuronal function.
*Not approved by the US FDA or Philippine FDA for any cognitive indication. Compounded by prescription only.
Non-invasive
Eye-drop simplicity
Safe
FDA approved molecules
Innovative
Novel delivery system to the Central Nervous System (CNS)
The Science
INSULIN plays a critical role in brain energy metabolism, synaptic signaling, memory, and learning.
In states of cognitive decline, the brain often develops resistance to insulin, a condition often described as “type 3 diabetes.” Insulin supplementation has been shown to improve cognition by enhancing neuronal function and supporting synaptic plasticity. However, the blood-brain barrier limits the utility of the systemic route of administration.
Claridrops™ builds on decades of published works in the fields of endocrinology, ophthalmology, and neurology.
By delivering insulin through to the eyes, Claridrops™ aims to bypass systemic barriers and provide a novel route into the central nervous system. The proprietary formulation of Claridrops™ is designed to improve corneal penetration and facilitate distribution of insulin to the optic nerve and further along peri‑neural pathways into the target areas of the brain.
Insulin is not usually absorbed when it is applied to the eye topically.
Because Claridrops™ repurposes insulin, a well‑characterized, FDA‑approved molecule, TheThinkClinic.com is able to bring the benefits of this new technology today through ethical prescribing and legal compounding.
Frequently Asked Questions (FAQ)
Still Have Questions?
Is insulin safe to use in eye drops?
Insulin has an extensive safety history in off-label ophthalmic use. Our research and compounding process prioritize ocular tolerability and dosing safety.
How do the drops reach the brain?
The eye is connected to the brain through nerves and fluid pathways. Research has shown that insulin delivered as eye drops can move along peri‑neural routes and reach the central nervous system, where it may influence cognitive metabolism and signaling.
Is this product FDA approved?
The active ingredient, insulin, is FDA‑approved for other uses. The compounded ophthalmic formulation is personalized and requires a prescription. As a personalized compounded drug, it is not FDA‑reviewed.
Who can access this treatment
Where legally permitted, patients may undergo telehealth intake with our affiliated physicians. If appropriate, a patient‑specific compounded preparation may be prescribed and filled by our partner pharmacy.
What does “patent pending” mean?
It means the novel formulation and use of ophthalmic insulin for cognitive purposes has been filed with patent authorities and is under review.
